Program News
News and stories about members of the UNC Lineberger Cancer Prevention and Control Research Program
-
Stein discusses latest advances in sarcoma treatment, research
July is Sarcoma Awareness Month. Jake Stein, MD, MPH, shares that recent advances in targeted therapies, immunotherapy and radiation techniques are improving outcomes for patients diagnosed with this group of cancers.
-
UNC honors three cancer center members with 2025 Hettleman Prizes
Sarah Cohen, PhD, Marissa Hall, PhD, and Lindsey James, PhD, were awarded Hettleman Prizes, which recognizes UNC-Chapel Hill early-career faculty who exemplify groundbreaking and innovative research.
-
UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting
UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.
-
E-cigarette warnings lower vaping interest and raise quit intentions
E-cigarette warnings effectively discourage vaping without causing unintended consequences like increased cigarette smoking, according to a meta-analysis of 24 studies by UNC Lineberger’s Seth Noar, PhD, and colleagues.
-
UNC faculty and trainees to present at the world’s largest clinical cancer research meeting
UNC faculty and trainees will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.
-
UNC public service awards recognize Fort Bragg Public Health Partnership, Tylee Craft
The Carolina Center for Public Service honored two recipients with close ties to UNC Lineberger: the Fort Bragg Public Health Partnership and UNC student-athlete Tylee Craft.
-
Helping testicular cancer survivors navigate life after treatment
At UNC Lineberger, a dedicated testicular cancer survivorship program is helping patients move forward with confidence and support.
-
UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.
-
Immunotherapy and targeted therapy combination proves effective against metastatic colorectal cancer
UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer.
-
Electronic reporting of symptoms by cancer patients can improve quality of life and reduce emergency visits
The PRO-TECT randomized clinical trial was conducted to assess the real-world impact of electronic patient-reported outcomes symptom monitoring on clinical outcomes compared to usual care.
-
Improving health of military personnel and families through collaboration, research
UNC Lineberger is leading an innovative cancer prevention partnership at Fort Bragg that is designed to reduce tobacco use and promote HPV vaccination.
-
UNC researchers presenting research advances at American Society of Hematology annual meeting
Nearly two dozen UNC faculty members and trainees will present research and participate in scientific symposia and educational sessions at the ASH Annual Meeting.
-
UNC researchers awarded up to $10M to leverage data science to accelerate cancer diagnosis and optimize delivery of precision oncology
A team of UNC-Chapel Hill researchers has received nearly $10 million in funding to develop the Cancer Identification and Precision Oncology Center.
-
UNC Lineberger members recognized for highly cited research
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
-
Home testing kits and coordinated outreach substantially improve colorectal cancer screening rates
Previous research has shown this kind of intervention is effective in large, integrated health systems. However, its impact was unknown in federally qualified health centers and the patient populations they serve.